Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Viral infections

COVID-19 death rate under 1% when unconfirmed cases considered, researchers estimate

Researchers have estimated the death rate from COVID-19 to be 0.66% when unconfirmed cases are taken into account.

Open access article

The Royal Pharmaceutical Society has made this article free to access in order to help healthcare professionals stay informed about an issue of national importance.

To learn more about coronavirus, please visit: https://www.rpharms.com/resources/pharmacy-guides/wuhan-novel-coronavirus

PCR machine

Source: Shutterstock.com

Confirmation of current SARS-CoV 2 infection relies on detection of viral DNA after polymerase chain reaction testing

The estimated death rate from COVID-19 is 0.66% when unconfirmed cases are taken into account, research published in Lancet Infectious Diseases (30 March 2020) suggests[1].

The team studied data on 70,117 confirmed COVID-19 cases in China, as well as 689 international residents of Wuhan, China, who were repatriated to their home countries and tested for the virus by polymerase chain reaction.

The overall fatality ratio for confirmed cases in China was 1.38% (95% confidence interval [CI]) 1.23–1.53%), with substantially higher ratios in older age groups: up to 13.4% in those aged 80 years or older (95% CI 11.2–15.9%).

Among the repatriated group, 6 (0.87%) of the 689 people were infected with COVID-19. By combining this information with case fatality ratios across age groups in China, and adjusting for undiagnosed and unconfirmed cases, the researchers estimated the infection fatality ratio to be 0.66%.

The researchers explained that their estimated overall case fatality ratio was lower than the crude case fatality ratio for China (3.67%) and other estimates in the literature because they accounted for bias in detection across age groups, as younger patients typically exhibit milder symptoms.

“Our estimates of the underlying infection fatality ratio of this virus will inform assessments of health effects likely to be experienced in different countries, and thus decisions around appropriate mitigation policies to be adopted,” the team concluded.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20207886

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • International Research in Healthcare

    International Research in Healthcare

    Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.

    £38.00Buy now
  • FASTtrack: Pharmacology

    FASTtrack: Pharmacology

    FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.

    £28.00Buy now
  • Prescribing Medicines for Children

    Prescribing Medicines for Children

    Prescribing Medicines for Children is designed to improve understanding on all aspects of paediatric prescribing, from the development of suitable drugs through to their practical administration.

    £60.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.